JULIANNE HUMASON: Open Payments
NPI 1518517481 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 16 payments from 11 companies in 2025. Trend: 2023 $119 · 2024 $144 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $196 |
| UCB, Inc. | 1 | $140 |
| ARGENX US, INC. | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $80 |
| COLOPLAST CORP | 1 | $68 |
| Chiesi USA, Inc. | 1 | $27 |
| Teleflex LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
Products named: Rystiggo, MOUNJARO, VYVGART, REXULTI, Titan, ZEPBOUND, MYCAPSSA, UROLIFT.
Industry payments across CA — which companies pay providers there.
